Advancing Stem Cell Therapies Through Expert GMP iPSC Manufacturing
Cellipont’s iPSC services provide end-to-end solutions for researchers and biopharma companies seeking to develop safe, effective, and scalable cell therapies. Our team combines advanced technologies, custom protocols, and deep regulatory expertise to support every stage of your iPSC program—from initial cell sourcing to clinical-grade manufacturing.
Our Capabilities
Custom Reprogramming & Differentiation Protocols
- Development of robust, efficient protocols for reprogramming somatic cells into iPSCs.
- Expertise in generating a wide range of differentiated cell types tailored to your therapeutic needs.
- Integration of gene editing technologies (e.g., CRISPR) for precise genetic modifications.
Cell Banking & Scale-Up
- Creation and qualification of Master Cell Banks (MCB) and Working Cell Banks (WCB) under GMP conditions.
- Scalable manufacturing processes to support both preclinical and clinical supply needs.
- Fill-finish and release testing services to ensure product quality and consistency.
GMP Facility & Quality Systems
- State-of-the-art GMP manufacturing suites designed for iPSC production.
- Stringent quality control and batch record management systems.
- Comprehensive QA/QC workflows aligned with FDA, EMA, and ICH guidelines.
iPSC Manufacturing Workflow
Our streamlined GMP iPSC manufacturing workflow ensures efficiency, traceability, and regulatory compliance at every step:
- Cell Sourcing & Reprogramming: Selection of high-quality donor cells and reprogramming to iPSCs using validated protocols.
- Gene Editing (Optional): Incorporation of gene editing for disease modeling or therapeutic enhancement.
- Expansion & Banking: Scalable expansion and banking of iPSC lines under GMP conditions.
- Differentiation: Directed differentiation into target cell types using custom protocols.
- Quality Control & Release: Rigorous testing for identity, purity, potency, and safety prior to product release.
Key Capabilities
Our team's expertise in GMP iPSC manufacturing ensures your program benefits from best-in-class science, technology, and operational excellence.
Therapeutic Applications of iPSC-derived Cells
iPSC-derived cells have broad applications across regenerative medicine, disease modeling, and drug discovery:
- Allogeneic and autologous cell therapies
- Disease modeling for rare and common conditions
- High-throughput drug screening platforms
- Toxicology and safety assessment studies
GMP & Regulatory Compliance
Cellipont Bioservices is committed to the highest standards of quality and compliance:
- Adherence to FDA, and EMA guidelines for GMP iPSC manufacturing.
- Robust QA/QC systems, including electronic batch records and real-time monitoring.
- Certifications and regulatory audits to ensure ongoing compliance and client confidence.
Why Choose Cellipont Bioservices
Choosing the right manufacturing partner is critical for the success of your iPSC-derived cell therapy program. Here’s why Cellipont stands out:
Proven Track Record
Decades of experience in cell therapy manufacturing.
Flexible, Client-Centric Approach
Customizable solutions to fit your project’s unique needs.
Cutting-Edge Technology
Investment in the latest tools and platforms for iPSC development.
Transparent Communication
Dedicated project managers and clear timelines.
What Our Customers Are Saying
"Cellipont brings deep technical capabilities and a shared sense of urgency to help us translate the promise of ERNA-101 into a clinically viable therapy. This collaboration marks an important milestone in advancing our iMSC platform, which we believe has the potential to reshape the treatment landscape for patients with advanced solid tumors."
Related Services
We support a wide range of therapeutic platforms:
Ready to take the next step in GMP iPSC manufacturing?
Connect with Cellipont Bioservices today and discover how our expertise and iPSC services can accelerate your program and deliver life-changing therapies to patients worldwide.
Let’s work together